Skip to main content
. Author manuscript; available in PMC: 2010 Jan 1.
Published in final edited form as: Cancer Res. 2009 Jan 1;69(1):151–160. doi: 10.1158/0008-5472.CAN-08-0442

Figure 4.

Figure 4

Immunofluorescent staining of AR in LNCaP-Zeo and GRP4-9 cells in response to AZD0530 treatment: AR localization in the nuclei of GRP4-9 cells under androgen-deprived conditions is inhibited by AZD0530. Numbers on the right represent the percentage of cells with AR nuclear localization.